Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-01-23

Clinical Trial Update: Hydroxychloroquine Efficacy in Chronic Urticaria [NA]

View source ↗

Summary

A Vanderbilt University-sponsored trial evaluating hydroxychloroquine for chronic urticaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Vanderbilt University | Conditions: Chronic Urticaria | NA | Status: WITHDRAWN